46596 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 03
15:55 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Simeon Gutman ★★☆☆☆ #2667 | Equal Weight | $108.00→ $98.00-9.3% |
|
Sep 03
15:55 UTC
|
NTSK
Netskope
|
◎ Target | Meta Marshall ★★★★☆ #830 | Overweight | $14.00→ $16.00+14.3% |
|
Sep 03
15:55 UTC
|
NTAP
NetApp
|
◎ Target | David Vogt ★★☆☆☆ #2325 | Neutral | $160.00→ $171.00+6.9% |
|
Sep 03
15:55 UTC
|
NTAP
NetApp
|
◎ Target | Aaron Rakers ★★★☆☆ #2128 | Equal Weight | $180.00→ $190.00+5.6% |
|
Sep 03
15:55 UTC
|
MDT
Medtronic
|
◎ Target | Priya Sachdeva not yet tracked | Buy | $100.00→ $110.00+10.0% |
|
Sep 03
15:55 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Matthew Niknam ★★★☆☆ #2180 | Buy | $69.00→ $70.00+1.4% |
|
Sep 03
15:55 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | David Vogt ★★☆☆☆ #2325 | Neutral | $65.00→ $59.00-9.2% |
|
Sep 03
15:55 UTC
|
GLXY
Galaxy Digital
|
◎ Target | James Faucette ★★★☆☆ #2169 | Overweight | $37.00→ $48.00+29.7% |
|
Sep 03
15:55 UTC
|
FIVE
Five Below
|
◎ Target | Michael Lasser ★★★☆☆ #1680 | Buy | $285.00→ $325.00+14.0% |
|
Sep 03
15:55 UTC
|
FIVE
Five Below
|
◎ Target | Scot Ciccarelli ★★★☆☆ #1192 | Buy | $273.00→ $297.00+8.8% |
|
Sep 03
15:55 UTC
|
EIX
Edison International
|
◎ Target | Richard Sunderland ★★★☆☆ #1002 | Hold | $77.00→ $63.00-18.2% |
|
Sep 03
15:55 UTC
|
CXM
Sprinklr
|
◎ Target | Elizabeth Porter ★★★☆☆ #1946 | Equal Weight | $7.00→ $8.00+14.3% |
|
Sep 03
15:55 UTC
|
AVGO
Broadcom
|
◎ Target | William Stein ★★☆☆☆ #2427 | Buy | $550.00→ $520.00-5.5% |
|
Sep 03
15:55 UTC
|
AFRM
Affirm
|
◎ Target | Matthew Coad ★★★☆☆ #1741 | Buy | $83.00→ $85.00+2.4% |
|
Sep 03
15:55 UTC
|
AVGO
Broadcom
|
↓ Downgrade | Timothy Arcuri ★★☆☆☆ #2735 | Buy→ Hold | |
|
Sep 03
15:55 UTC
|
AVGO
Broadcom
|
↑ Upgrade | firm only | Outperform | |
|
Sep 03
15:55 UTC
|
AVGO
Broadcom
|
↑ Upgrade | firm only | Buy | |
|
Sep 03
14:55 UTC
|
SNOW
Snowflake
|
◎ Target | Raimo Lenschow ★★★☆☆ #1823 | Equal Weight | $332.00→ $384.00+15.7% |
|
Sep 03
14:55 UTC
|
PS
Pershing Square
|
◎ Target | Robert Ryan not yet tracked | Equal Weight | $34.00→ $36.00+5.9% |
|
Sep 03
14:55 UTC
|
PHR
Phreesia
|
◎ Target | Stan Berenshteyn ★★★☆☆ #1554 | Equal Weight | $9.00→ $10.00+11.1% |
|
Sep 03
14:55 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Edward Kelly ★★★☆☆ #2139 | Overweight | $100.00→ $90.00-10.0% |
|
Sep 03
14:55 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Steven Shemesh ★★☆☆☆ #2410 | Outperform | $121.00→ $124.00+2.5% |
|
Sep 03
14:55 UTC
|
NTSK
Netskope
|
◎ Target | Matthew Hedberg ★★★☆☆ #1799 | Outperform | $18.00→ $20.00+11.1% |
|
Sep 03
14:55 UTC
|
NTAP
NetApp
|
◎ Target | Erik Woodring ★★☆☆☆ #2278 | Equal Weight | $173.00→ $191.00+10.4% |
|
Sep 03
14:55 UTC
|
NTAP
NetApp
|
◎ Target | Tim Long ★★☆☆☆ #2632 | Overweight | $199.00→ $219.00+10.1% |
|
Sep 03
14:55 UTC
|
MMED
MiniMed Group
|
◎ Target | Kallum Titchmarsh ★★★★☆ #915 | Overweight | $19.00→ $21.00+10.5% |
|
Sep 03
14:55 UTC
|
LII
Lennox International
|
◎ Target | Betsy Graseck not yet tracked | Underweight | $450.00→ $375.00-16.7% |
|
Sep 03
14:55 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Aaron Rakers ★★★☆☆ #2128 | Equal Weight | $67.00→ $54.00-19.4% |
|
Sep 03
14:55 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Meta Marshall ★★★★☆ #830 | Overweight | $69.00→ $67.00-2.9% |
|
Sep 03
14:55 UTC
|
FIVE
Five Below
|
◎ Target | John Heinbockel ★★★☆☆ #2227 | Buy | $250.00→ $290.00+16.0% |
|
Sep 03
14:55 UTC
|
FIVE
Five Below
|
◎ Target | Joseph Feldman not yet tracked | Outperform | $280.00→ $305.00+8.9% |
|
Sep 03
14:55 UTC
|
FIVE
Five Below
|
◎ Target | Edward Kelly ★★★☆☆ #2139 | Overweight | $260.00→ $295.00+13.5% |
|
Sep 03
14:55 UTC
|
FIVE
Five Below
|
◎ Target | Simeon Gutman ★★☆☆☆ #2667 | Equal Weight | $235.00→ $300.00+27.7% |
|
Sep 03
14:55 UTC
|
CVX
Chevron
|
◎ Target | Sam Margolin ★★★☆☆ #1275 | Overweight | $226.00→ $230.00+1.8% |
|
Sep 03
14:55 UTC
|
TCOM
Trip.com Group
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Sep 03
14:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Sep 03
14:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | Michael Turrin ★★★★☆ #944 | Overweight→ Equal Weight | $50.00→ $18.00-64.0% |
|
Sep 03
13:55 UTC
|
SNOW
Snowflake
|
◎ Target | Ittai Kidron ★★★☆☆ #1055 | Outperform | $400.00→ $475.00+18.8% |
|
Sep 03
13:55 UTC
|
SNOW
Snowflake
|
◎ Target | Brad Reback ★★★☆☆ #2021 | Buy | $350.00→ $450.00+28.6% |
|
Sep 03
13:55 UTC
|
SNOW
Snowflake
|
◎ Target | Gil Luria ★★★★☆ #893 | Buy | $300.00→ $450.00+50.0% |
|
Sep 03
13:55 UTC
|
SLF
Sun Life Financial
|
◎ Target | Kevin Heal ★★★★☆ #379 | Buy | $81.00→ $88.00+8.6% |
|
Sep 03
13:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Laura Chico ★☆☆☆☆ #3101 | Neutral | $30.00→ $23.00-23.3% |
|
Sep 03
13:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Whitney Ijem ★☆☆☆☆ #3092 | Buy | $83.00→ $37.00-55.4% |
|
Sep 03
13:55 UTC
|
NTAP
NetApp
|
◎ Target | Mehdi Hosseini ★★★☆☆ #1126 | Neutral | $185.00→ $195.00+5.4% |
|
Sep 03
13:55 UTC
|
NTAP
NetApp
|
◎ Target | Matt Bryson ★★★☆☆ #1482 | Neutral | $150.00→ $170.00+13.3% |
|
Sep 03
13:55 UTC
|
ILMN
Illumina
|
◎ Target | Jasper Hellweg ★★★★☆ #618 | Buy | $180.00→ $235.00+30.6% |
|
Sep 03
13:55 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Tim Long ★★☆☆☆ #2632 | Overweight | $67.00→ $79.00+17.9% |
|
Sep 03
13:55 UTC
|
GOLD
Gold.com
|
◎ Target | Brian McNamara ★★★☆☆ #2134 | Buy | $70.00→ $65.00-7.1% |
|
Sep 03
13:55 UTC
|
DRTS
Alpha Tau Medical
|
◎ Target | Lukas Shumway not yet tracked | Overweight | $17.00→ $30.00+76.5% |
|
Sep 03
13:55 UTC
|
AXON
Axon Enterprise
|
◎ Target | John Staszak ★★★★☆ #743 | Buy | $460.00→ $600.00+30.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.